| Title : Use of Dipeptidyl Peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: a propensity score analysis from the CORONADO study - Roussel_2021_Diabetes.Obes.Metab__ |
| Author(s) : Roussel R , Darmon P , Pichelin M , Goronflot T , Abouleka Y , Ait Bachir L , Allix I , Ancelle D , Barraud S , Bordier L , Carlier A , Chevalier N , Coffin-Boutreux C , Cosson E , Dorange A , Dupuy O , Fontaine P , Fremy B , Galtier F , Germain N , Guedj AM , Larger E , Laugier-Robiolle S , Laviolle B , Ludwig L , Monier A , Montanier N , Moulin P , Moura I , Prevost G , Reznik Y , Sabbah N , Saulnier PJ , Serusclat P , Vatier C , Wargny M , Hadjadj S , Gourdy P , Cariou B |
| Ref : Diabetes Obes Metab , : , 2021 |
| Abstract : Roussel_2021_Diabetes.Obes.Metab__ |
| ESTHER : Roussel_2021_Diabetes.Obes.Metab__ |
| PubMedSearch : Roussel_2021_Diabetes.Obes.Metab__ |
| PubMedID: 33528920 |